Previous close | 116.83 |
Open | 116.02 |
Bid | 116.51 x 800 |
Ask | 116.54 x 1100 |
Day's range | 115.95 - 117.05 |
52-week range | 89.67 - 121.64 |
Volume | |
Avg. volume | 6,124,432 |
Market cap | 202.524B |
Beta (5Y monthly) | 0.72 |
PE ratio (TTM) | 36.72 |
EPS (TTM) | 3.17 |
Earnings date | 16 Oct 2024 - 21 Oct 2024 |
Forward dividend & yield | 2.20 (1.88%) |
Ex-dividend date | 15 Jul 2024 |
1y target est | 124.04 |
In the latest trading session, Abbott (ABT) closed at $117.11, marking a +0.58% move from the previous day.
ABT made its CGM system Lingo available in the United States. The system can be used by consumers aged 18 years and older who are not on insulin.
Abbott Laboratories launched its newest CGM in the U.S. on Thursday. The biosensor named Lingo is the first-ever for people without diabetes.